Insulet Reports Second Quarter 2015 Financial Results

Leerink Partners Raises Price Target on Insulet (PODD) Following 2Q15 Results

Leerink Partners reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $44.00 (from $40.00), following the company's 2Q15 earnings report. PODD reported 2Q15 sales of $75.6M, in line with the July 29th preannouncement, and coming in ~$4M ahead of the Street.

Analyst Danielle Antalffy commented, "Last night, PODD reported 2Q15 sales of $75.6M (+5%y/ y) -- in line with the July 29th... More

Piper Jaffray Raises Price Target on Insulet (PODD) to $41 Following 2Q Earnings

Piper Jaffray reiterated an Overweight rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $41.00 (from $36.00), following the company's 2Q earnings report. PODD reported 2Q revenues of $75.6M, in-line with preannounced results, and above consensus of $68.9M and company guidance of $67M-$70M. Management reaffirmed full year revenue guidance... More

Benchmark Downgrades Insulet Corporation (PODD) to Hold

Benchmark downgraded Insulet Corporation (NASDAQ: PODD) from Buy to Hold with a price target of $30 (unchanged).

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $34.07 yesterday.

Insulet (PODD) Misses Q2 EPS by 14c, Sales Beat

Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.27), $0.14 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $75.6 million versus the consensus estimate of $70.75 million.

Insulet sees FY2015 revenue of $300-320 million, versus the consensus of $304.4 million.

"We are very... More